Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
6
×
life sciences
national blog main
fda
boston blog main
boston top stories
clinical trials
startups
national top stories
raleigh-durham blog main
san francisco blog main
alexion pharmaceuticals
alnylam pharmaceuticals
boston
drugs
hepatitis b
investing
medical device
new york blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
4d molecular therapeutics
abbvie
achaogen
acne
adams street partners
agenus
amyotrophic lateral sclerosis (als)
antibiotics
astrazeneca
auris health
autoimmune disorders
avexis
bayer
beijing
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
What
disease
6
×
drug
6
×
medicines
deal
hepatitis
infectious
pharma
pharmaceuticals
therapeutics
year
adds
alliance
alternative
approved
areas
autoimmune
bacteria
bio
biopharma
biosciences
bio’s
brii
building
business
candidate
caught
causing
companies
company
developer
dicerna
digital
earlier
epidemic
established
exited
expensive
eye
fatty
fda
Language
unset
Current search:
disease
×
deals
×
drug
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed